Federal contractor profile
Osivax
Paris 8, ILE-DE-FRANCE · Not a small business
UEI M4YDKJJRJYC7 · CAGE FBDR2
Contracts won
2
since Jul 2025 · last Sep 2025
Total value
$99M
including options
Buying offices
1
government offices it sold to
Usual competition
1 offer
100% of its wins had one offer
Who it sells to
Barda - Aspr / Daappo / Barda Dcma
Administration For Strategic Preparedness And Response · 2 wins · $99M
What it wins
Health R&D Services; Health Care Services; Basic Research
PSC AN11 · 1 win · $99M
Health R&D Services; Health Care Services; R&D Administrative Expenses
PSC AN14 · 1 win · $744K
Ending in the next 12 months
Contracts that end soon are usually re-bid. These could be openings for a competitor.
Oxivax - Aoi #28: Influenza Vaccine Innovation. Advancing Metagenomic Next-Generation Sequencing Based Agnostic Diagnostics For Viral Pathogens The Overall Objective Of This Contract Is To Prepare The Ind Package For Ovx836+Sq Adjuvant.
Barda - Aspr / Daappo / Barda Dcma · ends Mar 2027 · $744K
Is this your company?
Claim this profile free, and see the open contracts that fit what you win: who else bids, what the government paid last time, and what to bid.
From federal contract award records (SAM.gov), base awards over $10K since fiscal year 2024, updated daily. Values include options where reported.
ZukoBid is an independent service, not affiliated with or endorsed by any government agency. Figures come from public records and may contain errors; always check the official listing before you bid. Spotted an error about Osivax? Request a correction.